Jelly Roll's wife Bunnie XO said she got sick and "s--t my brains out" after "microdosing" the weight loss drug tirzepatide, which is often marketed as Mounjaro or Zepbound.

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

$468 $279 for your first year. Make up your own mind. Build robust opinions with the FT’s trusted journalism. Offer available here until 24th October.

Spirit shares took a nosedive on news of a possible bankruptcy filing. The budget carrier and its bondholders have discussed ...

When paired with diet and exercise, Ozempic is an effective ... GLP-1 medications for you doesn’t restrict or eliminate any foods can be expensive health coaches not guaranteed to be ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug ... database in 2022, while Zepbound was added this April.

Oct 2 (Reuters) - The U.S. Food and Drug Administration ... been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said. Eli Lilly's tirzepatide, sold as Zepbound for weight loss and ...